Videos

In this Pharmaceutical Commerce video interview, Emma Banks, CEO of ramarketing, discusses the biggest roadblocks to the widespread adoption of novel modalities, and how new biotech companies can navigate the current funding slowdown while securing the capital crucial for their success.

Navigating the Current Funding Slowdown While Securing Capital

In this Pharmaceutical Commerce video interview, Emma Banks, CEO of ramarketing, discusses how the balance between onshoring and outsourcing will evolve, how long will the current slowdown in biotech investment likely last, and what factors might influence its duration.

How Long Will the Current Slowdown in Biotech Investment Last?

In an interview with Pharma Commerce Associate Editor Don Tracy, Corey Ford, VP, Reimbursement, Policy Insights, Cencora, provides a look at his recent webinar focused on the implications of the Inflation Reduction Act. 

Cencora VP of Reimbursement & Policy Insights Discusses Implications of the Inflation Reduction Act

In an interview with Pharma Commerce associate editor Don Tracy, Lynn Kirkpatrick, PhD, CEO, Ensysce Biosciences, discusses the FDA's Breakthrough Therapy Designation for PF614-MPAR, which focuses on protecting patients from drug overdoses.

Lynn Kirkpatrick, PhD, CEO, Ensysce Biosciences, Discusses the Recent Breakthrough Therapy Designation for PF614-MPAR

Articles

In an interview with Pharma Commerce Associate Editor Don Tracy, Ron Lanton, Partner, Lanton Law PLLC, discusses recent moves by CVS and Express Scripts to follow Mark Cuban's drug plus model.

Ron Lanton, Partner, Lanton Law PLLC, Discusses New Drug Plus Pricing Models

Partner for Archbow Consulting discusses the conference, the IRA, and specifics of PAP business rules

Trade & Channel Strategies 2023: An Interview with Douglas Bock of Archbow Consulting

Bill Trombetta, PhD, discusses successfully navigating what he calls “the coming perfect storm” in healthcare. 

Trade & Channel Strategies 2023: An Interview with Bill Trombetta, PhD, Professor Emeritus, St. Joseph's University

Bayer executive talks Enable Holistic Hub and Provider Services panel.

Trade & Channel Strategies 2023: An Interview with Bayer's Spencer Miller

Founding Partner of Curatio Scientia speaks on her upcoming panel at Trade & Channel Strategies 2023. 

Trade & Channel Strategies 2023: An Interview with Cheryl Allen of Curatio Scientia

Lexicon Pharmaceuticals exec discusses upcoming Enable Holistic Hub and Provider Services panel. 